Small cap companies with market capitalization between $5Million and $500 Million, listed in US or Canada, with share price greater than $5 and whose ratio of Total cash+short term investments to Total Assets is greater than 50%
| Company Name |
Exchange:Ticker |
Total Cash & ST Inv [LQ C$M] |
Cash & ST Inv / Total Assets |
Exchanges |
Market Cap [26-Oct] (C$m) |
| Rigel Pharmaceuticals, Inc. |
NasdaqGM:RIGL |
198.9 |
96% |
Nasdaq Global Market (NasdaqGM) |
455.4 |
| Harbinger Group Inc. |
NYSE:HRG |
149.3 |
96% |
New York Stock Exchange (NYSE) |
103.5 |
| Vanda Pharmaceuticals, Inc. |
NasdaqGM:VNDA |
219.7 |
93% |
Nasdaq Global Market (NasdaqGM) |
220.3 |
| ArQule Inc. |
NasdaqGM:ARQL |
116.0 |
92% |
Nasdaq Global Market (NasdaqGM) |
259.1 |
| Terreno Realty Corp. |
NYSE:TRNO |
172.2 |
92% |
New York Stock Exchange (NYSE) |
170.5 |
| Medivation, Inc. |
NasdaqGM:MDVN |
247.5 |
91% |
Nasdaq Global Market (NasdaqGM) |
402.3 |
| AVEO Pharmaceuticals, Inc. |
NasdaqGM:AVEO |
113.6 |
90% |
Nasdaq Global Market (NasdaqGM) |
473.3 |
| Maxygen, Inc. |
NasdaqGM:MAXY |
164.5 |
89% |
Nasdaq Global Market (NasdaqGM) |
193.3 |
| China Digital TV Holding Co., Ltd. |
NYSE:STV |
248.5 |
83% |
New York Stock Exchange (NYSE) |
410.1 |
| Nabi Biopharmaceuticals |
NasdaqGM:NABI |
107.8 |
83% |
Nasdaq Global Market (NasdaqGM) |
217.9 |
| Infinity Pharmaceuticals, Inc. |
NasdaqGM:INFI |
126.6 |
81% |
Nasdaq Global Market (NasdaqGM) |
162.1 |
| IFM Investments Limited |
NYSE:CTC |
126.5 |
80% |
New York Stock Exchange (NYSE) |
255.8 |
| AMAG Pharmaceuticals, Inc. |
NasdaqGM:AMAG |
306.7 |
77% |
Nasdaq Global Market (NasdaqGM) |
428.2 |
| Altius Minerals Corp. |
TSX:ALS |
168.4 |
77% |
The Toronto Stock Exchange (TSX) |
307.5 |
| Affymax, Inc. |
NasdaqGM:AFFY |
150.5 |
75% |
Nasdaq Global Market (NasdaqGM) |
135.3 |
| eLong Inc. |
NasdaqGM:LONG |
135.0 |
70% |
Nasdaq Global Market (NasdaqGM) |
433.5 |
| Duoyuan Global Water Inc. |
NYSE:DGW |
223.7 |
70% |
New York Stock Exchange (NYSE) |
314.3 |
| Codexis, Inc. |
NasdaqGM:CDXS |
106.4 |
70% |
Nasdaq Global Market (NasdaqGM) |
345.3 |
| NPS Pharmaceuticals, Inc. |
NasdaqGM:NPSP |
141.4 |
69% |
Nasdaq Global Market (NasdaqGM) |
417.3 |
| Ultratech, Inc. |
NasdaqGM:UTEK |
189.0 |
68% |
Nasdaq Global Market (NasdaqGM) |
460.7 |
| Retail Opportunity Investments Corp. |
NasdaqGM:ROIC |
288.9 |
68% |
Nasdaq Global Market (NasdaqGM) |
418.2 |
| ShoreTel, Inc. |
NasdaqGM:SHOR |
122.9 |
68% |
Nasdaq Global Market (NasdaqGM) |
255.9 |
| China-Biotics, Inc. |
NasdaqGM:CHBT |
169.5 |
65% |
Nasdaq Global Market (NasdaqGM) |
284.3 |
| TeleNav, Inc. |
NasdaqGM:TNAV |
119.7 |
65% |
Nasdaq Global Market (NasdaqGM) |
213.2 |
| Furiex Pharmaceuticals, Inc. |
NasdaqGM:FURX |
105.1 |
63% |
Nasdaq Global Market (NasdaqGM) |
115.0 |
| DragonWave Inc. |
TSX:DWI |
104.8 |
62% |
The Toronto Stock Exchange (TSX) |
290.8 |
| CEVA Inc. |
NasdaqGM:CEVA |
105.3 |
59% |
Nasdaq Global Market (NasdaqGM) |
381.2 |
| Oplink Communications Inc. |
NasdaqGM:OPLK |
156.3 |
58% |
Nasdaq Global Market (NasdaqGM) |
373.5 |
| Senvest Capital Inc. |
TSX:SEC |
237.2 |
57% |
The Toronto Stock Exchange (TSX) |
186.4 |
| Chatham Lodging Trust |
NYSE:CLDT |
104.7 |
56% |
New York Stock Exchange (NYSE) |
178.5 |
| Accuray Incorporated |
NasdaqGM:ARAY |
154.2 |
55% |
Nasdaq Global Market (NasdaqGM) |
406.9 |
| Jiangbo Pharmaceuticals, Inc |
NasdaqGM:JGBO |
115.4 |
54% |
Nasdaq Global Market (NasdaqGM) |
91.6 |
| SWS Group Inc. |
NYSE:SWS |
2,482.3 |
53% |
New York Stock Exchange (NYSE) |
224.4 |